Lung cancer is the leading cause of cancer deaths worldwide, with approximately 1.8 million people dying from this disease each year. Most patients are diagnosed after symptoms have appeared and the disease has progressed to an advanced stage (Stage III or IV), which explains the current worldwide five-year survival rate of just 20 percent. In contrast, the survival rate for small lung tumors that are treated at Stage 1A is as high as 90 percent. This significant difference highlights a critical
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Boosting Clinical Trial Recruitment Requires Humanity – and Technology
Clinical trials should be a time of promise for better patient outcomes, as they explore new ways to potentially help patients suffering from a variety of conditions. Instead, this phase of treatment development is often met with exasperation as patients, researchers, and drug developers deal with the many barriers to clinical trial recruitment and access. There are two central – and intrinsically linked – problems with the current state of clinical trial recruitment in the U.S.:
Read More
17 Executive Hospital/Health System Predictions to Watch in 2023
Vijay Kedar, Co-Founder and CEO at Tomorrow Health Health systems will realize their challenges are not transitory but systemic: This year saw health systems facing a myriad of compounding threats – from historic inflation exacerbating their cost structures, front-line clinician burnout driving widespread labor shortages, and increased capacity issues that left patients in hospital facilities one full day longer than in the prior year. As the financial markets turned south, many institutions
Read More
2022 Healthcare Investment, M&A, IPO Market Trends/Insights
What You Should Know: - The latest edition of SVB's Healthcare Investments and Exits report provides information on VC fundraising, investments and M&A and IPO trends - along with subsector analysis and video commentary for each. - Healthcare trends indicate US healthcare VC investment was healthy in 2022 despite an economic downturn. There's plenty of dry powder to deploy; however, investments and exits are slowing due to the volatile market. Trends and Insights – Healthcare
Read More
6 Executive Health Data Predictions to Watch in 2023
Kevin Agatstein, CEO at Kaid Health In 2023 I predict that unstructured medical data, which makes up the majority of a patient’s chart, will become too valuable to ignore by both providers and payers. Driven in part by the growth of Medicare Advantage and oncology, both of which require the data within medical notes rather than just claims and labs data, organizations will start to use their unstructured EMR data in entirely new ways. Rob Cohen, CEO at Bamboo Health In today’s
Read More
Caris Life Sciences and ConcertAI Partner to Accelerate Drug Development and Novel Research
What You Should Know: - Caris Life Sciences®(Caris), a molecular science, artificial intelligence (AI) and machine learning technology company actively developing and delivering innovative solutions to revolutionize healthcare, and ConcertAI, an oncology real-world evidence data and AI technology company, announced a unique partnership to align the two companies' oncology capabilities. - The strategic partnership will create one of the largest translational and clinical
Read More
C2i Genomics & AstraZeneca Partner to Advance Cancer Therapy
What You Should Know: - C2i Genomics, a cancer intelligence company, today announced a strategic collaboration with AstraZeneca, a global life sciences and pharmaceutical leader. - The two companies have collaborated to evaluate the potential of whole-genome minimal residual disease (MRD) testing across solid cancers. - Expanding on a completion of AstraZeneca’s accelerator BeyondBio SCALE program for start-ups and successful technology validation, C2i Genomics and AstraZeneca
Read More
Biomica Raises $20M to Advance its Pipeline of Microbiome-based Therapeutics
What You Should Know: - Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd raises $20M led by Shanghai Healthcare Capital (SHC). - The financing round will enable Biomica to forge ahead, developing its pipeline of microbiome-based therapeutics. Biomica plans to use the proceeds to complete its current BMC128 phase 1 immuno-oncology study and advance to phase 2 clinical trial; scale up and complete GMP
Read More
Q/A: Podimetrics CEO Talks Preventing Diabetic Amputations
Diabetes prevention is one of the biggest challenges in the healthcare industry as more than 37 million Americans (11.3% of the population) suffer from this debilitating chronic disease. As we close the year out, we sat down with Jon Bloom, MD, CEO and Co-founder of diabetic healthcare tech company Podimetrics to learn how the industry and his company are working to implement health equity change to serve patients living with advanced diabetes. The company’s FDA-cleared SmartMat provides a
Read More
Pangea Biomed Adds $5M for its Multi-Cancer Response Predictor
What You Should Know: - Pangea Biomed, the biotech company behind ENLIGHT, the multi-cancer response predictor improving the effectiveness of precision oncology, announced $5M in additional funding reaching a total seed round of $12M. - The latest fundraising is led by angel investor Danny Tocatly and existing investor NFX, and will be used to expand US operations, drive commercial partnerships, and scale product offerings. Expanding US Operations and Fostering Commercial
Read More